Results 141 to 150 of about 134,072 (327)

Impact of primary tumor clinicopathological factors on prognosis after hepatic resection for rectal liver metastases

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This retrospective study evaluates the prognostic factors in patients undergoing curative hepatic resection for rectal cancer liver metastases. It identifies lateral lymph node metastasis and perineural invasion as significant prognostic factors. Moreover, patients with these factors required nonsurgical treatment in the early postoperative period ...
Tomofumi Uotani   +9 more
wiley   +1 more source

Outcomes of simultaneous resection for elderly patients with colorectal liver metastasis: A propensity score matching analysis

open access: yesCancer Medicine, Volume 11, Issue 24, Page 4913-4926, December 2022., 2022
482 CRLM patients treated by simultaneous resection were categorized into the young group (age 70 years) and the elderly group (age GreaterEqual;70 years). Although elderly patients receiving simultaneous resection of CRLM have worse OS, similar PFS was reached in the multivariate analysis after propensity score matching.
Qichen Chen   +5 more
wiley   +1 more source

Response to “the Future of Pain Medicine: Emerging Technologies, Treatments, and Education” [Response to Letter]

open access: yesJournal of Pain Research
Matthew Slitzky,1 R Jason Yong,2 Giuliano Lo Bianco,3 Trent Emerick,4 Michael E Schatman,5,6 Christopher L Robinson2 1Burke Rehabilitation, Montefiore Health System, White Plains, NY, USA; 2Department of Anesthesiology, Perioperative, and Pain Medicine ...
Slitzky M   +5 more
doaj  

Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Preoperative GPS2 is an independent poor prognostic factor in patients with colorectal cancer and synchronous peritoneal metastases, and surgical resection does not improve prognosis in patients with GPS2. Preoperative GPSs may be used as indicators for surgical resection of synchronous peritoneal metastases.
Kosuke Fujimoto   +31 more
wiley   +1 more source

Dose of intra‐operative opioids has no impact on recurrence or survival in primary liver cancer

open access: yesCancer Medicine, Volume 11, Issue 24, Page 4927-4934, December 2022., 2022
Kaplan‐meier curves for recurrence‐free and overall survial of high‐dose and low‐dose groups. No significant difference in recurrence‐free survial (A) or overall survial (B) after surgery was noted when comparing high‐dose with low‐dose groups. Abstract Background Intra‐operative use of opioid analgesics might have an impact on cancer recurrence and ...
Liuyuan Zhao   +9 more
wiley   +1 more source

Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial

open access: yesJournal of Translational Medicine
Background Preclinical evidence suggests that young plasma has beneficial effects on multiple organ systems in aged mice. Whether young plasma exerts beneficial effects in an aging human population remains highly controversial.
Brice Gaudilliere   +24 more
doaj   +1 more source

Perioperative outcomes of esophagectomy after doublet versus docetaxel‐based triplet neoadjuvant chemotherapy in older patients: A nationwide inpatient database study in Japan

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
In this nationwide inpatient database study of 5229 patients aged 70–79 years who underwent esophagectomy for cancer after neoadjuvant chemotherapy, overlap propensity score weighting analysis showed that neoadjuvant docetaxel‐based triplet regimen (docetaxel, cisplatin, and 5‐fluorouracil) was not associated with a higher incidence of perioperative ...
Yuki Hirano   +11 more
wiley   +1 more source

Mesenchymal stem cells: A novel treatment option for primary sclerosing cholangitis

open access: yesCell Biology International, Volume 47, Issue 2, Page 467-479, February 2023., 2023
Abstract Primary sclerosing cholangitis (PSC) is a progressive liver disease for which there is no effective therapy. Hepatocytes and cholangiocytes from a PSC patient were cocultured with mesenchymal stem cells (MSCs) to assess in vitro change. A single patient with progressive PSC was treated with 150 million MSCs via direct injection into the common
Amy L. Lightner   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy